MENU
About
►
About Us
Organization
Our History
News
►
News
Technologies
►
OralPAS®
OralPAS Pro®
MUCR™
R&D
►
Pipeline
D07001 GemOral
D0191801 Oral Insulin
D0282102 Bendamustine RTD
Products
►
Anti-infection Agents
Contrast Agents
Oncology Agents
Immunological Agents
Drugs for Rare Diseases
Active Pharmaceutical Ingredient
Investors
►
Financial Information
►
Company Profile
Monthly Revenue
Financial Statements
Corporate Governance
►
Board Meeting
Committee
Internal Audit
Rule of Procedure
Corporate Social Responsibility
Shareholders Services
►
Annual Reports
Shareholders' Meetings
Announcements
Contact
Contacts
►
Contact Information
Career Opportunities
中
InnoPharmax
About
About Us
Organization
Our History
News
News
Technologies
OralPAS®
OralPAS Pro®
MUCR™
R&D
Pipeline
D07001 GemOral
D0191801 Oral Insulin
D0282102 Bendamustine RTD
Products
Anti-infection Agents
Contrast Agents
Oncology Agents
Immunological Agents
Drugs for Rare Diseases
Active Pharmaceutical Ingredient
Investors
Financial Information
Company Profile
Monthly Revenue
Financial Statements
Corporate Governance
Board Meeting
Committee
Internal Audit
Rule of Procedure
Corporate Social Responsibility
Shareholders Services
Annual Reports
Shareholders' Meetings
Announcements
Contact
Contacts
Contact Information
Career Opportunities
中
Investor Relations
Financial Information
Company Profile
Monthly Revenue
Financial Statements
Corporate Governance
Board Meeting
Committee
Internal Audit
Rule of Procedure
Corporate Social Responsibility
Shareholders Services
Annual Reports
Shareholders' Meetings
Announcements
Contact
Error loading images. One or more images were not found.
Annual Reports
>
Shareholders Services
>
Investor Relation
>
home
Annual Reports
(Ticker Symbol: 4172)
2016 Annual Report
2015 Annual Report
2014 Annual Report
2013 Annual Report
2012 Annual Report
2011 Annual Report
uGear Design
-
Website Info.
